| dc.contributor.author | Khosla, M C | |
| dc.contributor.author | Chaturvedi, N C | |
| dc.contributor.author | Smeby, R R | |
| dc.contributor.author | Bumpus, F M | |
| dc.date.accessioned | 2010-05-08T06:54:05Z | |
| dc.date.available | 2010-05-08T06:54:05Z | |
| dc.date.issued | 1968 | |
| dc.identifier.citation | Biochemistry, 7,1968,3417 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/557 | |
| dc.description.abstract | 1-Isoleucine,5-isoleucine]-angiotensin II and [3-proline,5-isoleucine]-angiotensin II were synthesized by the solid-phase method using dicyclohexylcarbodiimide as the condensing agent. The formation of the arginyl-proline bond was extremely difficult under conditions used. The former had about 25% pressor and 50% oxytocic activities giving further evidence the acidity of the j3-carboxyl is unnecessary. The latter possessed 40% pressor and 80% oxytocic activities of the parent angiotensin. This relatively high biological activity was surprising because of the limitation on possible peptide conformations imposed by this cyclic amino acid. [5-Alanine]-angiotensin II was prepared by solid phase using N-ethyl-5-phenylisoxazolium-3-sulfonate as the condensing agent. This peptide possessed approximately 5% of pressor activity of angiotensin II indicating the importance of branched side chain of valine or isoleucine occurring naturally in this position. | en |
| dc.format.extent | 4021631 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.subject | 1-Isoleucine | en |
| dc.subject | dicyclohexylcarbodiimide | en |
| dc.subject | N-ethyl-5-phenylisoxazolium-3-sulfonate | en |
| dc.subject | angiotensin | en |
| dc.title | Synthesis of [l-Isoleucine-, 3-Proline-, and 5-Alanine ]-angiotensins 11 | en |
| dc.type | Article | en |